The effect of curcumin-piperine dietary supplement in people with type 2 diabetes and hypertriglyceridemia

Phase 3

Recruiting

• Conditions: Type 2 diabetes mellitus.; Type 2 diabetes mellitus

• Registration Number: IRCT20121216011763N50
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Willingness to participate in the study
Age: 18-65 years old
Type 2 diabetes (fasting blood sugar above 126 mg / dL)
Hypertriglyceridemia (triglyceride above 150 mg / dL) has been diagnosed.

Exclusion Criteria

Pregnancy and lactation
People with type 1 diabetes and tasteless diabetes
Insulin injection
Smoking
Heart, lung, kidney, malignant cancer, immune system disorders, addiction or mental illness

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum lipids. Timepoint: Blood samples are taken at the beginning and end of the study. Method of measurement: Blood samples.;Blood glucose. Timepoint: Blood samples are taken at the beginning and end of the study. Method of measurement: Blood samples.

Secondary Outcome Measures

Name	Time	Method
Cholesterol. Timepoint: Before and after the intervention. Method of measurement: Blood samples using enzymatic methods.;High-density lipoprotein (HDL). Timepoint: Before and after the intervention. Method of measurement: Blood samples using enzymatic methods.;Low density lipoprotein (LDL). Timepoint: Before and after the intervention. Method of measurement: Blood samples using enzymatic methods.;Inflammatory factor (hs-CRP). Timepoint: Before and after the intervention. Method of measurement: Blood samples using enzymatic methods.